Abstract
Heparin or heparin-like heparan sulfate proteoglycans are obligatory for activity of the heparin-binding fibroblast growth factor (FGF) family. Heparin interacts independently of FGF ligand with a specific sequence (K18K) in one of the immunoglobulin-like loops in the extracellular domain of the FGF receptor tyrosine kinase transmembrane glycoprotein. A synthetic peptide corresponding to K18K inhibited heparin and heparin-dependent FGF binding to the receptor. K18K and an antibody to K18K were antagonists of FGF-stimulated cell growth. Point mutations of lysine residues in the K1i8K sequence abrogated both heparin- and ligand-binding activities of the receptor kinase. The results indicate that the FGF receptor is a ternary complex of heparan sulfate proteoglycan, tyrosine kinase transmembrane glycoprotein, and ligand.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1918-1921 |
| Number of pages | 4 |
| Journal | Science |
| Volume | 259 |
| Issue number | 5103 |
| DOIs | |
| State | Published - 1993 |
ASJC Scopus subject areas
- General
Fingerprint
Dive into the research topics of 'An essential heparin-binding domain in the fibroblast growth factor receptor kinase'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS